Cancer cell-selective promoter recognition accompanies antitumor effect by glucocorticoid receptor-targeted gold nanoparticle.

Nanoparticles, such as gold nanoparticles (GNP), upon convenient modifications perform multi tasks catering to many biomedical applications. However, GNP or any other type of nanoparticles is yet to achieve the feat of intracellular regulation of endogenous genes of choice such as through manipulation of a gene-promoter in a chromosome. As for gene modulation and delivery, GNP (or other nanoparticles) showed only limited gene therapy potential, which relied on the delivery of 'exogenous' genes invoking gene knockdown or replacement. Practically, there are no instances for the nanoparticle-mediated promoter regulation of 'endogenous' genes, more so, as a cancer selective phenomenon. In this regard, we report the development of a simple, easily modifiable GNP-formulation, which promoted/up-regulated the expression of a specific category of 'endogenous' genes, the glucocorticoid responsive genes. This genetic up-regulation was induced in only cancer cells by modified GNP-mediated transcriptional activation of its cytoplasmic receptor, glucocorticoid receptor (GR). Normal cells and their GR remained primarily unperturbed by this GNP-formulation. The most potent gene up-regulating GNP-formulation down-regulated a cancer-specific proliferative signal, phospho-Akt in cancer cells, which accompanied retardation of tumor growth in the murine melanoma model. We show that GR-targeted GNPs may find potential use in the targeting and modulation of genetic information in cancer towards developing novel anticancer therapeutics.

[1]  Qing Zhao,et al.  Gold nanoparticle wires for sensing DNA and DNA/protein interactions. , 2014, Nanoscale.

[2]  Chao Lu,et al.  Nonionic fluorosurfactant as an ideal candidate for one-step modification of gold nanorods. , 2014, Nanoscale.

[3]  Zhiqiang Gao,et al.  Gold nanoparticle-based exonuclease III signal amplification for highly sensitive colorimetric detection of folate receptor. , 2014, Nanoscale.

[4]  Guo-Feng Luo,et al.  Therapeutic nanomedicine based on dual-intelligent functionalized gold nanoparticles for cancer imaging and therapy in vivo. , 2013, Biomaterials.

[5]  D. Ye,et al.  Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma , 2013, Nature Communications.

[6]  J. Schwartz,et al.  Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia , 2013, Oncogene.

[7]  N. Khlebtsov,et al.  Gold nanoparticles in biomedical applications: recent advances and perspectives. , 2012, Chemical Society reviews.

[8]  D. Hirst,et al.  Gold nanoparticles as novel agents for cancer therapy. , 2012, The British journal of radiology.

[9]  Xin Shang,et al.  Size-dependent endocytosis of single gold nanoparticles. , 2011, Chemical communications.

[10]  Arthur Chiou,et al.  Size-dependent endocytosis of gold nanoparticles studied by three-dimensional mapping of plasmonic scattering images , 2010, Journal of nanobiotechnology.

[11]  Amitava Das,et al.  Fabrication and characterization of an inorganic gold and silica nanoparticle mediated drug delivery system for nitric oxide , 2010, Nanotechnology.

[12]  M. El-Sayed,et al.  Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis. , 2010, Journal of the American Chemical Society.

[13]  Yuqiang Jiang,et al.  Bioimaging with Two‐Photon‐Induced Luminescence from Triangular Nanoplates and Nanoparticle Aggregates of Gold , 2009 .

[14]  D. Astruc,et al.  Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. , 2009, Chemical Society reviews.

[15]  J. M. Kumar,et al.  Selective cancer targeting via aberrant behavior of cancer cell-associated glucocorticoid receptor. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[16]  Alaaldin M. Alkilany,et al.  Gold nanoparticles in biology: beyond toxicity to cellular imaging. , 2008, Accounts of chemical research.

[17]  D. Mukhopadhyay,et al.  Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. , 2008, Cancer research.

[18]  V. Labhasetwar,et al.  Biodegradable nanoparticles for cytosolic delivery of therapeutics. , 2007, Advanced drug delivery reviews.

[19]  David C. Martin,et al.  Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. , 2006, Biomaterials.

[20]  G. Navis,et al.  The role of the cytochrome P450 3A5 enzyme for blood pressure regulation in the general Caucasian population , 2005, Pharmacogenetics and genomics.

[21]  M. Leonard,et al.  Potentiation of Glucocorticoid Activity in Hypoxia through Induction of the Glucocorticoid Receptor1 , 2005, The Journal of Immunology.

[22]  R. Kofler,et al.  Glucocorticoid-induced apoptosis and glucocorticoid resistance in acute lymphoblastic leukemia , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[23]  V. Labhasetwar,et al.  Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles. , 2004, Molecular pharmaceutics.

[24]  Alexander M. Klibanov,et al.  Conjugation to gold nanoparticles enhances polyethylenimine's transfer of plasmid DNA into mammalian cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Cidlowski,et al.  The glucocorticoid receptor: coding a diversity of proteins and responses through a single gene. , 2002, Molecular endocrinology.

[26]  N Nonomura,et al.  Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer. , 2001, Journal of the National Cancer Institute.

[27]  O Pelkonen,et al.  Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line. , 2000, American journal of respiratory cell and molecular biology.

[28]  M. Garabedian,et al.  Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms , 1997, Molecular and cellular biology.

[29]  P. Chambon,et al.  Mutation of isoleucine 747 by a threonine alters the ligand responsiveness of the human glucocorticoid receptor. , 1996, Molecular endocrinology.

[30]  E. Bresnick,et al.  Evidence that the 90-kDa heat shock protein is necessary for the steroid binding conformation of the L cell glucocorticoid receptor. , 1989, The Journal of biological chemistry.

[31]  R. Evans,et al.  Primary structure and expression of a functional human glucocorticoid receptor cDNA , 1985, Nature.

[32]  J. Gustafsson,et al.  Purification of the glucocorticoid receptor from rat liver cytosol. , 1979, The Journal of biological chemistry.

[33]  Yong Liao,et al.  Physiological regulation of Akt activity and stability. , 2010, American journal of translational research.

[34]  J. Ashwell,et al.  Glucocorticoids in T cell development and function*. , 2000, Annual review of immunology.

[35]  C. Kellendonk,et al.  New insights into glucocorticoid and mineralocorticoid signaling: lessons from gene targeting. , 2000, Advances in Pharmacology.

[36]  K. Yamamoto,et al.  Steroid receptor regulated transcription of specific genes and gene networks. , 1985, Annual review of genetics.